Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
MiVital is a Swiss biotechnology company specializing in advanced drug delivery systems designed to enhance the bioavailability of lipophilic substances. The company's proprietary MiVital Technology utilizes a unique micellization process to transform fat-soluble compounds into water-soluble forms, significantly increasing absorption rates in the human body. Their portfolio includes high-bioavailability formulations of vitamins, plant extracts like curcumin, and cannabinoids. MiVital operates as both a product developer and a technology provider for the pharmaceutical, nutraceutical, and cosmetic industries. By overcoming the natural absorption barriers of the digestive tract, the company aims to maximize the efficacy of health-promoting ingredients.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on MiVital.